UniXell Biotechnology

UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.

ActiveBioTech

Updated: Feb 17, 2026 ·

Recent News & Mentions

UniXell Biotechnology has raised $7.2M across 1 funding round. Most recently, it raised $7.2M Series A in February 2026.

Total Raised

$7.2M

Valuation

N/A

Date	Round	Lead Investors	Other Investors
Feb 11, 2026	$7.2M Series A		Pan-Lin Capital, Quancun Venture Capital, Waigaoqiao Private Equity Fund

UniXell Biotechnology has raised $7.2M across 1 funding round.

Total Raised

$7.2M

Valuation

N/A

How much funding has UniXell Biotechnology raised?

UniXell Biotechnology has raised $7.2M in total across 1 funding round.

Who are UniXell Biotechnology's investors?

UniXell Biotechnology's investors include Pan-Lin Capital, Quancun Venture Capital, Waigaoqiao Private Equity Fund.

How much funding has UniXell Biotechnology raised?

UniXell Biotechnology has raised $7.2M in total across 1 funding round.